MCM
CLBT icon

Manchester Capital Management’s Cellebrite CLBT Stock Holding History

Manchester Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$19 – 1368
2025
Q3 		$19 Hold
1
– – ﹤0.01% 1289
2025
Q2 		$16 Hold
1
– – ﹤0.01% 1200
2025
Q1 		$20 Hold
1
– – ﹤0.01% 1169
2024
Q4 		$23 Hold
1
– – ﹤0.01% 1153
2024
Q3 		$17 Buy
+1
New +$15 ﹤0.01% 1175

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Manchester Capital Management's CLBT Position: Q4 2025 in Review

Manchester Capital Management sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 1 share — an estimated $19 sold.

Manchester Capital Management first reported a position in CLBT in Q3 2024 and held it in 5 quarters. The position peaked at $23 in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • Manchester Capital Management reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • Manchester Capital Management sold 1 Cellebrite share in Q4 2025, an estimated $19.
  • Manchester Capital Management first reported a position in Cellebrite in Q3 2024 and held it in 5 quarters.
  • Manchester Capital Management's Cellebrite position peaked at $23 in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on Manchester Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.